Gout - a guide for the general and acute physicians.

Abstract

Gout is the most prevalent inflammatory arthritis and affects 2.5% of the general population in the UK. It is also the only arthritis that has the potential to be cured with safe, inexpensive and well tolerated urate-lowering treatments, which reduce serum uric acid by either inhibiting xanthine oxidase - eg allopurinol, febuxostat - or by increasing the renal excretion of uric acid. Of these, xanthine oxidase inhibitors are used first line and are effective in 'curing' gout in the vast majority of patients. Gout can be diagnosed on clinical grounds in those with typical podagra. However, in those with involvement of other joints, joint aspiration is recommended to demonstrate monosodium urate crystals and exclude other causes of acute arthritis, such as septic arthritis. However, a clinical diagnosis of gout can be made if joint aspiration is not feasible. This review summarises the current understanding of the pathophysiology, clinical presentation, investigations and treatment of gout.

• Authors: Abhishek Abhishek, Edward Roddy, Michael Doherty
• Journal: Clinical medicine (London, England) (Clin Med (Lond)) Vol. 17 Issue 1 Pg. 54-59 (Feb 2017) ISSN: 1473-4893 [Electronic] England
• PMID: 28148582 (Publication Type: Journal Article, Review)
• Copyright: © Royal College of Physicians 2017. All rights reserved.

Topics

• Gout (diagnosis, epidemiology, physiopathology, therapy)
• Humans
• Practice Guidelines as Topic